Status:
COMPLETED
Immersive Virtual Reality for the Non-pharmacological Management of Parkinson's Disease
Lead Sponsor:
Campus Neurológico Sénior
Conditions:
Parkinson Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate the feasibility, safety and efficacy of an immersive virtual reality (IVR) exergaming using a head-mounted display in Parkinson's disease symptomatic con...
Eligibility Criteria
Inclusion
- Patients diagnosed with Parkinson's disease according to MDS criteria;
- Hoehn and Yahr stages between I-III (MED ON);
- Ability to perform the Time Up and Go test in normal pace and without assistance, in less than 11,5 seconds in ON state;
- Stable medication for the past 1 month;
- Ability to communicate with the investigator, to understand and comply with the requirements of the study;
- Able to provide written informed consent to participate in the study.
Exclusion
- Postural instability or freezing of gait in MED ON representing an increased risk of fall, according to the best clinical judgement;
- A Montreal Cognitive Assessment (MoCA) score \< 21;
- Presence of severe visual loss that could interfere with the ability to see the VR simulation as well as vertigo, epilepsy and psychosis;
- Unstable medical condition, including cardiovascular, pulmonary or musculoskeletal, that according to the clinician's judgment affect patients' ability to participate in the study;
- Inability to correctly respond to the assessment protocol according to the clinician's judgment or lack of support from caregiver for this effect.
Key Trial Info
Start Date :
January 19 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 12 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06052930
Start Date
January 19 2023
End Date
August 12 2023
Last Update
September 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CNS-Campus Neurológico
Lisbon, Portugal